NO20080175L - Sukkerbelagt tablett - Google Patents

Sukkerbelagt tablett

Info

Publication number
NO20080175L
NO20080175L NO20080175A NO20080175A NO20080175L NO 20080175 L NO20080175 L NO 20080175L NO 20080175 A NO20080175 A NO 20080175A NO 20080175 A NO20080175 A NO 20080175A NO 20080175 L NO20080175 L NO 20080175L
Authority
NO
Norway
Prior art keywords
coated tablet
sugar coated
sugar
unstable
oxygen
Prior art date
Application number
NO20080175A
Other languages
English (en)
Norwegian (no)
Inventor
Yoshihiro Uchiyama
Yoshinori Nakano
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37498554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20080175(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of NO20080175L publication Critical patent/NO20080175L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20080175A 2005-06-10 2008-01-10 Sukkerbelagt tablett NO20080175L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005171443 2005-06-10
PCT/JP2006/311618 WO2006132360A1 (fr) 2005-06-10 2006-06-09 Comprimé dragéifié

Publications (1)

Publication Number Publication Date
NO20080175L true NO20080175L (no) 2008-03-04

Family

ID=37498554

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080175A NO20080175L (no) 2005-06-10 2008-01-10 Sukkerbelagt tablett

Country Status (19)

Country Link
US (1) US20090030064A1 (fr)
EP (1) EP1889611A1 (fr)
JP (1) JPWO2006132360A1 (fr)
KR (1) KR20080014014A (fr)
CN (1) CN101193625A (fr)
AR (1) AR054133A1 (fr)
AU (1) AU2006256038A1 (fr)
BR (1) BRPI0611058A2 (fr)
CA (1) CA2610342A1 (fr)
CR (1) CR9523A (fr)
IL (1) IL187407A0 (fr)
MA (1) MA29540B1 (fr)
NO (1) NO20080175L (fr)
NZ (1) NZ563820A (fr)
PE (1) PE20070077A1 (fr)
RU (1) RU2407515C2 (fr)
TW (1) TW200716207A (fr)
WO (1) WO2006132360A1 (fr)
ZA (1) ZA200710333B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100121483A (ko) 2008-02-11 2010-11-17 다이닛본 스미토모 세이야꾸 가부시끼가이샤 용출성이 개선된 정제
TW201021832A (en) * 2008-09-30 2010-06-16 Astellas Pharma Inc Pharmaceutical composition for oral administration
KR20120049309A (ko) * 2009-09-02 2012-05-16 닛뽕소다 가부시키가이샤 하이드록시알킬셀룰로오스를 포함하는 코팅제
CN101804042A (zh) * 2010-04-16 2010-08-18 山东新华制药股份有限公司 普拉格雷片剂的制备方法
WO2014203029A1 (fr) * 2013-06-17 2014-12-24 Freescale Semiconductor, Inc. Programmation efficace dans un système asynchrone basé sur la résolution de conflits
FR3013186B1 (fr) * 2013-11-19 2019-07-19 Roquette Freres Nouveaux snacks non allergenes contenant des proteines vegetales
CN103977427A (zh) * 2014-05-08 2014-08-13 王�琦 一种糖衣产气粉配方及其制备方法
FR3067567B1 (fr) * 2017-06-19 2019-07-05 Roquette Freres Nouveau procede de drageification et formes solides drageifiees presentant des formes irregulieres
FR3089756B1 (fr) * 2018-12-17 2021-02-19 Roquette Freres Formes solides dragéifiées présentant une stabilité améliorée
JP7503420B2 (ja) * 2020-05-18 2024-06-20 東和薬品株式会社 フィンゴリモドを含む医薬組成物とその製造方法及び安定化方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981001100A1 (fr) * 1979-10-17 1981-04-30 Roquette Freres Procede de drageification dure au sorbitol et produits ainsi obtenus
JPH0816052B2 (ja) * 1988-11-21 1996-02-21 エスエス製薬株式会社 糖衣錠
JP3507211B2 (ja) * 1995-07-13 2004-03-15 三菱化学株式会社 糖衣液及び糖衣錠
WO2000034262A1 (fr) * 1998-12-04 2000-06-15 Takeda Chemical Industries, Ltd. Derives de benzofuranne, leur procede de preparation et leurs utilisations
JP2001139495A (ja) * 1999-11-19 2001-05-22 Shin Etsu Chem Co Ltd フィルムコーティング剤及び経口固形製剤
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
JP2002047174A (ja) * 2000-05-26 2002-02-12 Towa Chem Ind Co Ltd 無糖コーティング製剤及びその製造方法
DE10033023A1 (de) * 2000-07-07 2002-01-31 Biogrund Gmbh Filmüberzugszusammensetzung auf Basis von Zellulosederivaten und Zuckeralkoholen
JP2002179559A (ja) * 2000-10-06 2002-06-26 Takeda Chem Ind Ltd 薄層糖衣錠およびその製造方法
JP4824224B2 (ja) * 2001-08-28 2011-11-30 興和株式会社 糖衣製剤
JP2003095928A (ja) * 2001-09-27 2003-04-03 Kowa Co 糖衣製剤
JP2003113060A (ja) * 2001-10-02 2003-04-18 Lion Corp 発泡成分含有糖衣物
JP4336074B2 (ja) * 2001-11-15 2009-09-30 三菱商事フードテック株式会社 色調および食感が良好な硬質糖衣錠剤
AU2002366313A1 (en) * 2001-12-19 2003-06-30 Takeda Chemical Industries, Ltd. Solid compositions containng compounds unstable to oxygen and method for stabilization thereof
JP4590034B2 (ja) * 2002-01-31 2010-12-01 三菱商事フードテック株式会社 硬質糖衣製剤、糖衣液及び硬質糖衣製剤の製造方法
JP2004123578A (ja) * 2002-09-30 2004-04-22 Dainippon Ink & Chem Inc 糖衣錠およびその製造方法
JP2005298373A (ja) * 2004-04-08 2005-10-27 Kyowa Hakko Kogyo Co Ltd 吸水性アミノ酸含有糖衣錠剤
JP4984455B2 (ja) * 2004-08-18 2012-07-25 日本新薬株式会社 二重被覆錠剤

Also Published As

Publication number Publication date
US20090030064A1 (en) 2009-01-29
MA29540B1 (fr) 2008-06-02
TW200716207A (en) 2007-05-01
CR9523A (es) 2008-02-04
NZ563820A (en) 2010-03-26
KR20080014014A (ko) 2008-02-13
CA2610342A1 (fr) 2006-12-14
RU2007145426A (ru) 2009-06-20
RU2407515C2 (ru) 2010-12-27
JPWO2006132360A1 (ja) 2009-01-08
AU2006256038A1 (en) 2006-12-14
ZA200710333B (en) 2009-03-25
IL187407A0 (en) 2008-02-09
WO2006132360A1 (fr) 2006-12-14
BRPI0611058A2 (pt) 2011-02-22
PE20070077A1 (es) 2007-02-07
AR054133A1 (es) 2007-06-06
EP1889611A1 (fr) 2008-02-20
CN101193625A (zh) 2008-06-04

Similar Documents

Publication Publication Date Title
NO20080175L (no) Sukkerbelagt tablett
NO20053245L (no) Tabletter med modifisert frigjoring av bupropionhydroklorid.
CR10032A (es) Preparación sólida
CL2008000369A1 (es) Compuestos derivados de piridopirimidinonas; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar dolor, depresion, enfermedades cardiovasculares, enfermedades respiratorias y enfermedades psiquiatricas.
WO2009039951A3 (fr) Associations de principes actifs à propriétés insecticides et acaricides
MX2007014892A (es) Formas polimorficas del ester etilico del acido 3-[(2-{[4-(hexiloxicarbonilamino-imino-metil)-fenilamino]-metil}- 1-metil-h-bencimidazol-5-carbonil)-piridin-2-il--amino]propionico .
CL2008002998A1 (es) Compuestos derivados de piperazina-1-carboxamida, inhibidor de faah; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor inflamatorio o neuropatico, ansiedad y depresion.
NO20082285L (no) 3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer
CL2011000835A1 (es) Compuestos derivados de espiro-oxindol; moduladores de los canales de sodio; composicion farmaceutica que comprende a dicho compuesto; y uso en el tratamiento del dolor, depresion, enfermedades cardiovasculares, respiratorias, psiquiatricas, entre otras.
GEP20135816B (en) Insecticidal compounds
HRP20110094T8 (en) Solid preparation comprising alogliptin and pioglitazone
MX2009006675A (es) Inhibidores de cinasa mpk/erk.
WO2009082152A3 (fr) Activateurs de la glucokinase et compositions pharmaceutiques contenant ces derniers en tant qu'ingrédient actif
NO20090407L (no) Aerosolformulering for inhalering av beta agonister
GEP20146099B (en) Fused imidazole carboxamides as trpv3 modulators
ATE497760T1 (de) Filmueberzug fuer tabletten und kapletten
NO20082049L (no) Soppdrepende preparat
WO2005115392A3 (fr) 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides utilises comme modulateurs des recepteurs de la chimiokine
UA99250C2 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
AR065597A1 (es) Compuesto ester y su uso
WO2007113207A3 (fr) Formulations enduites
NO20070832L (no) Farmasoytiske preparat av piperazinderivater.
BRPI0701785A (pt) composto de 1,3-benzodioxol e emprego do mesmo
EA200801572A1 (ru) Фармацевтическая композиция, содержащая аморфный аторвастатин
AR060155A1 (es) Combinaciones de principios activos con propiedades insecticidas y acaricidas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application